Although HSCT has demonstrated promise in restoring immune function and decreasing IgE levels in affected individuals, additional research is required to clarify the specific biological mechanisms driving the clinical variations observed between the AD and AR inherited forms of HIES. This evidence concerns the gene IGHE and Alzheimer disease.